PRTN3 and Osteopenia: In addition, the presence of ACPA (anti-citrullinated peptides antibodies) is associated with an increased risk for osteopenia, particularly in the metacarpal area, as a consequence of the direct action of ACPA on osteoclasts, via IL-8 [12].